Introduction: Cancer treatment can significantly affect patient sexual function, through physical alterations and psychosocial impacts.
Aim: To investigate the incidence of sexual history documentation and counselling before, during and after cancer treatment.
Methods: Our group conducted a retrospective chart review at a major Australian cancer centre of premenopausal females aged 18-49 years diagnosed with cancer between 2017 and 2020. Data collected included primary diagnosis, stage of cancer, treatment(s) received, rates of remission or progression, involvement of a specialist gynaecologist, details of any sexual function/dysfunction discussions, and what treatment was offered.
Results: A total of 143 patients met inclusion criteria. Only 9.8% had their sexual history taken by their haematologist or oncologist, and 4.2% had their sexual histories documented by a gynaecologist. 40 patients had documented sexual dysfunction, most commonly vaginal dryness (55%), dyspareunia (28%), body image concerns (28%), bacterial vaginosis (20%), decreased libido (18%), vaginal GVHD (3%), and muscle spasms affecting coitus (3%). When these issues were discussed, they were often addressed by requesting gynaecologist, sexual health specialist and/or psychologist reviews, or by prescribing ointments, antifungals, antidepressants, lubricants, laser treatments, insertion of an intrauterine device, dilators, vaginal moisturisers, topical oestradiol or inserts.
Discussion: This rate of sexual function history taking is exceptionally low. Women’s sexual function concerns are rarely raised by physicians or volunteered by patients. To overcome existing barriers, there needs to be improved education of physicians on sexual dysfunction, implementation of systems to facilitate sexual history taking, and the provision of patient information sheets to facilitate knowledge and discussion.